Literature DB >> 15368494

Significant association between nonsyndromic oral clefts and arylhydrocarbon receptor nuclear translocator (ARNT).

Shuji Kayano1, Yoichi Suzuki, Kiyoshi Kanno, Yoko Aoki, Shigeo Kure, Atsushi Yamada, Yoichi Matsubara.   

Abstract

The etiology of nonsyndromic oral clefts (cleft lip, cleft palate, or cleft lip and palate) is still controversial, but is considered to involve both genetic and environmental factors. One of suspected environmental factors is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) found in tobacco, herbicides, contaminated soil, and food. TCDD administered during organogenesis in mice causes a high incidence of CP in fetuses. There is ample evidence that aryl hydrocarbon receptor (AHR), AHR nuclear translocator (ARNT), and cytochrome P450 1A1 (CYP1A1) are involved in TCDD metabolism. We assessed whether there is any association in the Japanese population of nonsyndromic oral clefts with single nucleotide polymorphisms (SNPs) in the AHR, ARNT, and CYP1A1 genes using transmission disequilibrium test (TDT) and case-control study. We identified and investigated three SNPs in ARNT; 567G/C (V189V), IVS12-19T/G, and 2117C/T (P706L). Two amino acid substitutions, R554L in AHR and I462V in CYP1A1, were also investigated. In the TDT, the C allele of ARNT 567G/C was preferentially transmitted to patients (P = 0.033). When a haplotype consisting of 567G/C and IVS12-19T/G in ARNT was considered, the preferential transmission of the CT (567C-IVS12-19T) haplotype was observed (P = 0.0012). In a case-control study, a significant association of IVS12-19T/G in ARNT was observed (P = 0.021). The SNPs studied in AHR and CYP1A1 were not associated with the disease. Our results suggest that ARNT is involved in the development of nonsyndromic oral clefts in the Japanese population. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15368494     DOI: 10.1002/ajmg.a.30023

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

Review 2.  Environmental mechanisms of orofacial clefts.

Authors:  Michael A Garland; Kurt Reynolds; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-10-30       Impact factor: 2.344

Review 3.  Progress toward discerning the genetics of cleft lip.

Authors:  Andrew C Lidral; Lina M Moreno
Journal:  Curr Opin Pediatr       Date:  2005-12       Impact factor: 2.856

4.  Copy Number Changes Identified Using Whole Exome Sequencing in Nonsyndromic Cleft Lip and Palate in a Honduran Population.

Authors:  Yi Cai; Karynne E Patterson; Frederic Reinier; Sarah E Keesecker; Elizabeth Blue; Michael Bamshad; Joseph Haddad
Journal:  Birth Defects Res       Date:  2017-07-27       Impact factor: 2.344

5.  A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1.

Authors:  Andrew C Lidral; Huan Liu; Steven A Bullard; Greg Bonde; Junichiro Machida; Axel Visel; Lina M Moreno Uribe; Xiao Li; Brad Amendt; Robert A Cornell
Journal:  Hum Mol Genet       Date:  2015-02-04       Impact factor: 6.150

6.  Sequence evaluation of FGF and FGFR gene conserved non-coding elements in non-syndromic cleft lip and palate cases.

Authors:  Bridget M Riley; Jeffrey C Murray
Journal:  Am J Med Genet A       Date:  2007-12-15       Impact factor: 2.802

7.  Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.

Authors:  Kathrin Klein; Stefan Winter; Miia Turpeinen; Matthias Schwab; Ulrich M Zanger
Journal:  Front Pharmacol       Date:  2010-11-02       Impact factor: 5.810

8.  Current concepts in genetics of nonsyndromic clefts.

Authors:  Jyotsna Murthy; Lvks Bhaskar
Journal:  Indian J Plast Surg       Date:  2009 Jan-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.